ReviewInnovation (Cambridge (Mass.))2021

Acquired resistance to third-generation EGFR-TKIs and emerging next-generation EGFR inhibitors.

Xiaojing Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.